In this episode of the Amplifiz Podcast, host Guillaume Villard sits down with Dr. Ankur Guptta to unpack one of the most important transformations in the pharmaceutical industry today: the evolution or reinvention of Medical Affairs.
What used to be a support function focused on compliance and scientific communication is now emerging as a strategic powerhouse—bridging science, business strategy, and patient outcomes.
What you’ll learn in this episode:
- What Medical Affairs really does (in simple terms) and why it’s critical across the entire product lifecycle
- How Medical Affairs evolved from a “rubber stamp” function to a core strategic pillar alongside R&D and Commercial
- Why COVID-19 accelerated the shift toward patient-centric healthcare models
- The growing importance of real-world evidence, data democratization, and precision medicine
- Whether pharma is truly patient-centric—or still product-driven
- How Medical Affairs can influence care pathways, clinical decision-making, and outcomes
- The rise of omnichannel engagement and how to improve HCP (healthcare professional) experience
- Leadership lessons for the AI era: balancing digital transformation with emotional intelligence (EI)
